Sun recalls cancer drug
Sun Pharmaceuticals has racked up its second recall of the year. Reuters reports that the drugmaker has recalled 200 vials of the cancer drug gemcitabine which were distributed in the US. Reuters notes that the voluntary recall, which started in April, was in the “Class II” category which means potential adverse reactions would be temporary.
The generics maker, which recently purchased beleaguered Ranbaxy Pharmaceuticals, recalled 2,528 bottles of its generic Glumetza diabetes drug earlier this year after a patient found epilepsy medication in his bottle.